866-997-4948(US-Canada Toll Free)

Global Pharmaceutical Contract Manufacturing Market 2016-2020

Published By :

Technavio

Published Date : Nov 2016

Category :

Cardiovascular Devices

No. of Pages : 81

About Pharmaceutical Contract Manufacturing

Contract manufacturing involves outsourcing manufacturing products to organizations, which helps the organizations offer the same services at a relatively lower cost. Typically, in the pharmaceutical and biotechnology sectors, the sourcing companies seek contract manufacturing services to restructure their resource deployment toward high skill areas such as R&D and marketing. Contract manufacturing has potential growth opportunities in emerging countries such as India and China.

Technavios analysts forecast the global pharmaceutical contract manufacturing market to grow at a CAGR of 6.91% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global pharmaceutical contract manufacturing market for 2016-2020. To calculate the market size, the report considers the revenue generated from various pharmaceutical drug manufacturing outsourcing activities.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Pharmaceutical Contract Manufacturing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Catalent
Lonza
Pfizer CentreOne

Other prominent vendors
Abbott
Aenova
Amgen
Apotex
Aspen
AstraZeneca
Aurobindo Pharma
Baxter
BERLIN-CHEMIE
Biocon
Biogen
Boehringer Ingelheim
Celltrion
Cipla
Coherus Biosciences
Daiichi Sankyo
Dr. Reddy's Laboratories
Eli Lilly
Emcure Pharmaceuticals
Eurofarma Laboratories
Fareva
Gedeon Richter
Gilead Sciences
GlaxoSmithKline (GSK)
Hospira
Impax Laboratories
Intas Pharmaceuticals
Janssen Pharmaceuticals
Lupin
Merck
Mitsubishi Tanabe Pharma
Momenta Pharmaceuticals
Natco Pharma
Nexus Pharmaceuticals
Novo Nordisk
Orchid Chemicals & Pharmaceuticals
Par Pharmaceutical
Parenteral Drugs India
Patheon
Piramal
Roche Holding
Sanofi
Synthon
Teva Pharmaceuticals
Valeant Pharmaceuticals
Zentiva
Zhejiang Huahai Pharmaceutical
Zydus Cadila

Market driver
High number of US FDA-approved manufacturing facilities in emerging countries.
For a full, detailed list, view our report

Market challenge
Capacity utilization issues and lack of information integration.
For a full, detailed list, view our report

Market trend
Huge demand for next-generation biologics.
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.



Table of Contents
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Pharmaceutical manufacturing outsourcing
Increased regulatory guidelines coupled with healthcare cost containment efforts
Rapid innovation and reduced product development lifecycle
High capital investment
PART 06: Market landscape
Market overview
Five forces analysis
PART 07: Market segmentation by type of contract manufacturing
Global API/bulk drug contract manufacturing market
Global FDF market
PART 08: Geographical segmentation
Global pharmaceutical contract manufacturing market by geography
Pharmaceutical contract manufacturing market in Americas
Pharmaceutical contract manufacturing market in APAC
Pharmaceutical contract manufacturing market in EMEA
PART 09: Key leading countries
PART 10: Market drivers
Increased focus on core competence
High number of US FDA-approved manufacturing facilities in emerging countries
Shorter time-to-market
PART 11: Impact of drivers
PART 12: Market challenges
Capacity utilization issues and lack of information integration
Growing global competition
Lack of manufacturing standardization
PART 13: Impact of drivers and challenges
PART 14: Market trends
Consolidation through vertical integration, alliances, and acquisitions
Huge demand for next-generation biologics
Value-added services
PART 15: Vendor landscape
Competitive scenario
PART 16: Key vendor analysis
Catalent
Lonza
Pfizer CentreOne
Other prominent vendors
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio

List of Exhibits

Exhibit 01: Service offerings
Exhibit 02: Overview of global pharmaceutical contract manufacturing market
Exhibit 03: Global pharmaceutical contract manufacturing market: Present and future scenario
Exhibit 04: Process of drug development
Exhibit 05: Value chain of pharmaceutical industry
Exhibit 06: Contract manufacturing market: Benefit analysis
Exhibit 07: Factors affecting pharmaceutical manufacturing outsourcing
Exhibit 08: Key factors and its impact on selection of CMOs
Exhibit 09: Global pharmaceutical contract manufacturing market: Market overview
Exhibit 10: CMO market growth
Exhibit 11: Overview of outsourced new drug abbreviations (NDAs) in CMO industry
Exhibit 12: Cost comparison of drug development in the US and India
Exhibit 13: Global pharmaceutical contract manufacturing market 2015-2020 ($ billions)
Exhibit 14: Average number of services outsourced by company type 2013-2015
Exhibit 15: Preference for choosing pharmaceutical outsourcing partners
Exhibit 16: Factors affecting the global pharmaceutical contract manufacturing market
Exhibit 17: Opportunities analysis: Global pharmaceutical contract manufacturing market
Exhibit 18: Growth of global pharmaceutical contract manufacturing market 2016-2020
Exhibit 19: Five forces analysis
Exhibit 20: Market segmentation based on type of contract manufacturing
Exhibit 21: Segment outlook
Exhibit 22: Market overview of global API/bulk drug manufacturing market
Exhibit 23: Global API/bulk drug contract manufacturing market 2015-2020 ($ billions)
Exhibit 24: Global API/bulk drug contract manufacturing market
Exhibit 25: Overview of API outsourcing manufacturing market
Exhibit 26: Market share of global FDF market 2015
Exhibit 27: Types of dosage forms
Exhibit 28: Lifecycle analysis of dosage formulations
Exhibit 29: Global FDF market 2015-2020 ($ billions)
Exhibit 30: Market share of global pharmaceutical contract manufacturing market 2015
Exhibit 31: Global pharmaceutical contract manufacturing market: Geography outlook 2015-2020
Exhibit 32: Global pharmaceutical contract manufacturing market: Current and future impact
Exhibit 33: Pharmaceutical contract manufacturing market in Americas 2015-2020 ($ billions)
Exhibit 34: Pharmaceutical contract manufacturing market in APAC 2015-2020 ($ billions)
Exhibit 35: Pharmaceutical contract manufacturing market in EMEA 2015-2020 ($ billions)
Exhibit 36: Key leading countries
Exhibit 37: Impact of drivers and challenges on global pharmaceutical contract manufacturing market
Exhibit 38: Competitive advantage
Exhibit 39: Examples of global pharmaceutical companies sourcing from CMOs
Exhibit 40: Impact of drivers
Exhibit 41: Capacity constraints by stage production 2015
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Impact of trends on global pharmaceutical contract manufacturing market
Exhibit 44: Major M&A in global pharmaceutical contract manufacturing market
Exhibit 45: Key vendors: Geographical presence 2015
Exhibit 46: Catalent: Profile
Exhibit 47: Catalent: Metrics analysis
Exhibit 48: Catalent: Growth strategy matrix
Exhibit 49: Catalent: Opportunity assessment
Exhibit 50: Lonza: Profile
Exhibit 51: Lonza: Metrics analysis
Exhibit 52: Lonza: Growth strategy matrix
Exhibit 53: Lonza: Opportunity assessment
Exhibit 54: Pfizer CentreOne: Profile
Exhibit 55: Pfizer CentreOne profile: Metrics analysis
Exhibit 56: Pfizer CentreOne: Growth strategy matrix
Exhibit 57: Pfizer CentreOne: Growth opportunity assessment

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *